Navigation Links
A Statement from Nova Oculus Concerning Clinical Trials for AMD in Canada
Date:3/14/2019

ON NOVEMBER 27, 2018, Nova Oculus Partners, LLC, issued a press release announcing that its Canadian partner, the Eye Machine Canada Inc., had been given approval to begin a clinical patient trial in Edmonton, Canada, using Nova Oculus’s pioneering technology for treating Age-Related Macular Degeneration (AMD).

The previous month, the medical devices bureau of Health Canada had granted an Investigational Testing Authorization for that trial. In making that announcement, the press release also reported that approval of the trial’s protocol and its investigator has been given by the clinical trials committee of the Health Research Ethics Board of Alberta (HREBA).

However, the press release’s assertion that approval of the protocol and the study’s investigator by the clinical trials committee was in error. It was the result of a misunderstanding based on a communication from HREBA that was assumed to be granting such approval. As of today’s date, the Eye Machine Canada Inc. is still awaiting the committee’s approval to proceed with the study.

Nova Oculus Partners, LLC, did not intend to suggest there was approval that at the time it did not believe had actually been granted. Moreover, upon learning of the actual status of the application, Nova Oculus made it clear in subsequent direct communications with its investors that the Eye Machine Canada is still awaiting approval from HREBA of its protocol.

Nova Oculus Partners, LLC, unreservedly apologizes to the members of HREBA, to its clinical trials committee, to the Eye Machine Canada Inc., and to the trial’s investigators for this misunderstanding.

Read the full story at https://www.prweb.com/releases/a_statement_from_nova_oculus_concerning_clinical_trials_for_amd_in_canada/prweb16165557.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Biohaven Files Registration Statement for Proposed Public Offering of its Common Shares
2. BioAmber Issues Statement Required by Section 610(b) of the NYSE MKT Company Guide
3. ASBMT Official Statement Opposing Executive Order on Immigration
4. ASBM Statement on Final Guidance for Industry Nonproprietary Naming of Biological Products
5. Neurotrope Issues Statement On Eli Lillys Solanezumab
6. BIOREM Responds to Statement of Claim
7. Intrexon Expresses Support for Resident Commissioner of Puerto Ricos Statements on Combatting Aedes aegypti Mosquitoes in Puerto Rico and Other U.S. Jurisdictions
8. Lone Star Value Issues Statement To Fellow Enzo Shareholders
9. NW Bio Statement Regarding Appointments
10. NW Bio Issues Statement on Highly Unusual Trading Activity
11. Depomed Issues Statement on Horizon Pharma plcs Unsolicited Exchange Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/12/2019)... JUPITER, Fla. (PRWEB) , ... April 12, 2019 ... ... will explore recent developments in neurotechnology and will educate about innovative tools and ... 3Q/2019. Check your local listings for more information. , This segment of Advancements ...
(Date:4/10/2019)... ... ... After more than three months of renovation, Lajollacooks4u is set to reveal ... and modern lighting and fixtures, and will provide additional workspace for the many guests ... in the demand for our team-building events and cooking classes over the last eleven ...
(Date:4/9/2019)... ... April 09, 2019 , ... Sonny Bar Lisa, or Sonny for short, is ... months. After a series of diagnostics, an MRI was performed which revealed Sonny ... the injury and found that VetStem Regenerative Cell Therapy may be a ...
(Date:4/8/2019)... ... April 08, 2019 , ... ... and collaboration solutions, announced today the launch of their app integration solution, CT ... of business and contact-orientated applications while using CT Cloud Voice and Skype for ...
Breaking Biology Technology:
(Date:5/22/2019)... ... May 22, 2019 , ... Leak Detection Associates ... for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is excited ... Processes (IPP) Ltd has been signed. The agreement will grant exclusive rights ...
(Date:5/21/2019)... ... ... Suvoda LLC , a SaaS provider of Interactive Response Technology (IRT) ... Inc. Magazine’s Best Workplaces for 2019, Inc.’s fourth annual ranking of the fast-growing private ... the newsstands on May 28, is the result of a comprehensive measurement of private ...
(Date:5/21/2019)... ... ... The ASGCT Clinical Trials Finder is a customizable search engine ... Data curated daily from ClinicalTrials.gov ensures the most up-to-date and applicable listings anywhere in ... in the development of the ASGCT Clinical Trials Finder reviewed the relevance ...
Breaking Biology News(10 mins):